Your session is about to expire
← Back to Search
DAISY Uterine Drain for Postpartum Hemorrhage
N/A
Recruiting
Led By Tetsuya Kawakita, MD
Research Sponsored by Raydiant Oximetry, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* The participants consist of women undergoing planned CD for reasons unrelated to this study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post caesarean delivery (cd)
Awards & highlights
Summary
This trial aims to gather feedback on using the DAISY uterine drain with wall suction. Obstetrical surgeons will be the users, and pregnant women undergoing cesarean delivery will be the
Who is the study for?
This trial is for pregnant women scheduled for a cesarean delivery (C-section) who haven't started active labor. They must consent to having the DAISY Uterine Drain placed during surgery and meet all other study requirements.
What is being tested?
The DAISy Uterine Drain device is being evaluated in this study. Obstetrical surgeons, considered 'users', will place the drain in participants during C-sections and provide feedback on its use and effectiveness.
What are the potential side effects?
Potential side effects are not explicitly listed, but may include discomfort or complications related to the placement of the uterine drain device during a cesarean section.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately post caesarean delivery (cd)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post caesarean delivery (cd)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Device evaluation
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
Ten women in whom the Daisy Drain is placed.
Find a Location
Who is running the clinical trial?
Raydiant Oximetry, Inc.Lead Sponsor
5 Previous Clinical Trials
81 Total Patients Enrolled
Tetsuya Kawakita, MDPrincipal InvestigatorEastern Virginia Medical School
2 Previous Clinical Trials
300 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger